Clear Distinction & Emily Early | Inaugural Interstate Adventure
Clear Distinction and Emily Early are joining the West Australian off the track representatives at the Adelaide International Horse Trials in the three-star long class.
Off the Track WA is proud to announce the sponsorship of this competitive combination for their first interstate campaign.
Clear Distinction, a 2009 gelding by Medal of Honor retired from racing in late 2012 after five starts for no placings under trainer Neville Parnham.
Clear Distinction, or Clarence to his friends, was purchased by Emily from Chelsea Lamb in October 2017. Together the pair have grown from competing at 95cm up to winning the four-star long class at the 2022 Wooroloo Three Day Event.
“Throughout our journey, he has taught me the value of patience, made me a better and more experienced rider. His bold, and willing personality, his need to please as well as his stubborn nature are what make him excel at eventing.” Emily says.
In addition to winning at Wooroloo CCI, Clarence and Emily have placed fourth and Best Performed Off the Track (BPOTT) Horse in the three-star long class at 2023 Capel Horse and Pony Club CCN, first in the 115cm OTT show jump class at the 2022 Horseland Young Horse Champs and third and BPOTT at the 2022 Brigadoon CCI in the three-star long class.
Clarence wasn’t always an easy ride, but he’s proven to be worth the trouble.
“He is now my favourite set of ears to sit behind. Every time we leave the start box, I can trust that he is going to try his best and give me all he has.” Emily says.
Clarence will begin his journey to South Australia along with Two Chances on Wednesday, to be joined by Emily on Saturday.
“I am incredibly proud of how far we have come in the last 12 months and I’m feeling very confident going into Adelaide. Our biggest goal is to make it through the finish flags on Sunday!” Emily says.
We can’t wait to see Clarence and Emily achieve their goals!
Images thanks to Waylib Photos, Silverfern Photography and Jordyn Colleran Photography.